🇺🇸 FDA
Patent

US 7446185

Her2/neu target antigen and use of same to stimulate an immune response

granted A61KA61K2039/5154A61K2039/5156

Quick answer

US patent 7446185 (Her2/neu target antigen and use of same to stimulate an immune response) held by The Regents of the University of California expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5154, A61K2039/5156, A61K2039/53, A61K38/00